Publications
Department Brüning
Journal Article (13)
2022
Journal Article
7 (21), e162753 (2022)
Dopamine-inhibited POMCDrd2+neurons in the ARC acutely regulate feeding and body temperature. JCI Insight
Journal Article
79 (8), 395 (2022)
Contribution of specific ceramides to obesity-associated metabolic diseases. Cellular and Molecular Life Sciences
Journal Article
130 (5), pp. 290 - 295 (2022)
Obesity - A Matter of Motivation? Experimental and Clinical Endocrinology & Diabetes
Journal Article
102 (3), pp. 560 - 576 (2022)
Caloric restriction reduces the pro-inflammatory eicosanoid 20-hydroxyeicosatetraenoic acid to protect from acute kidney injury. Kidney International
Journal Article
43 (2), pp. 314 - 328 (2022)
Arcuate nucleus-dependent regulation of metabolism - pathways to obesity and diabetes mellitus. Endocrine Reviews
Journal Article
246, 118738 (2022)
Advances in Spiral fMRI: A High-resolution Study with Single-shot Acquisition. NeuroImage
Journal Article
91 (10), pp. 898 - 906 (2022)
Maternal metabolic programming of the developing central nervous system – unified pathways to metabolic and psychiatric disorders. Biological Psychiatry
Journal Article
29 (4), pp. 680 - 689.e6 (2022)
An antisense transcript transcribed from Irs2 locus contributes to the pathogenesis of hepatic steatosis in insulin resistance. Cell Chemical Biology
Journal Article
14 (2), pp. 530 - 543 (2022)
Meeting Report: Aging Research and Drug Discovery. Aging
Journal Article
34 (2), pp. 269 - 284.e9 (2022)
Hypothalamic pregnenolone mediates recognition memory in the context of metabolic disorders. Cell Metabolism
Journal Article
4 (10), pp. 1402 - 1419 (2022)
HypoMap-a unified single-cell gene expression atlas of the murine hypothalamus. Nature Metabolism
Journal Article
66, 101626 (2022)
NIK/MAP3K14 in hepatocytes orchestrates NASH to hepatocellular carcinoma progression via JAK2/STAT5 inhibition. Molecular Metabolism
Journal Article
21 (5), pp. 821 - 830 (2022)
CD74-NRG1 fusions are oncogenic in vivo and induce therapeutically tractable ERBB2:ERBB3 heterodimerization. Molecular Cancer Therapeutics